Alzheimer's disease (AD) is a prevalent neurodegenerative disorder worldwide, primarily affecting older adults. Its epidemiology reveals a rising public health concern due to aging populations globally. As of recent estimates, approximately 50 million people worldwide live with dementia, with AD contributing to 60-70% of these cases. The prevalence is projected to triple by 2050, underscoring its impact on healthcare systems and economies. AD disproportionately affects women and those with a family history of the disease. Key risk factors include age, genetic predisposition (e.g., ApoE4 allele), and lifestyle factors such as cardiovascular health. Addressing AD's epidemiology necessitates enhanced awareness, early detection strategies, and ongoing research into effective treatments and preventive measures to mitigate its growing burden on societies worldwide.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States